Koene RJ, et al. - Among community-dwelling individuals without atrial fibrillation (AF), researchers assessed the distribution of embolic and thrombotic strokes and their association with the CHA₂DS₂-VASc score by looking at participants from the Atherosclerosis Risk in Communities (ARIC) Study who attended visit four (1996-98) and had no prior AF, stroke, or anticoagulant use (n=10,671). A follow-up was carried out through 2008, during which incident AF cases (n=760) and participants who started warfarin were censored. Findings showed that, the CHA₂DS₂-VASc score enabled ischemic stroke risk assessment in community-dwelling individuals without AF and showed good discriminatory ability for embolic stroke.